Development cooperation

Gavi, The Vaccine Alliance; COVAX AMC


Gavi, the Vaccine Alliance promotes global immunisation against epidemics and helps vaccinate children against life-threatening infectious diseases. Gavi’s main mission is to save lives and protect the world against the threat of epidemics by promoting equitable uptake and coverage of vaccines in the poorest countries. Due to its unique business model and partnerships, it has the power to negotiate better prices for the world's poorest countries and remove the commercial risks that manufacturers faced in serving this market. Gavi plays a critical role in strengthening primary health care (PHC), bringing us closer to the Sustainable Development Goal 3 of Universal Health Coverage (UHC), ensuring that no one is left behind. Gavi plays an important role also in the global COVID-19 response. Together with the Coalition for Epidemic Preparedness Innovations (CEPI) and World Health Organization (WHO) Gavi is also co-leading COVAX Facility (COVAX), the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. COVAX is leading efforts to secure fair and equitable access to safe and effective COVID-19 vaccines globally and is also a central instrument for EU's global vaccine solidarity. The contribution is directed to COVID-19 Vaccines Advance Market Commitment (COVAX AMC), which is governed by Gavi. The Gavi COVAX AMC is the financing instrument that will support the participation of 92 low- and middle-income economies in the COVAX Facility, enabling access to donor-funded doses of safe and effective COVID-19 vaccines.

More information to another website.)

Funding decision

15 270 754 €

Field of activity

  • Infectious disease control 100%

Funding channel

The Gavi Alliance



Code for the object of funding